Close Alert Banner
Skip to Content
Visit BORNOntario.caVisit BORN.ca
Contact Us
FR

BORN Ontario Logo

Contact Us icon
  • What We Screen For In Ontario
    • Trisomy 21 (Down Syndrome)
    • Trisomy 18 (Edwards Syndrome)
    • Nominate a Condition
  • Prenatal Screening Options
    • Is Prenatal Screening Right For Me?
    • Less than 14 Weeks' Pregnant
    • 14-21 Weeks' Pregnant
    • More than 21 Weeks' Pregnant
    • Twins and More Than Two Babies
    • Vanishing Twins
  • Results and Next Steps
    • Enhanced First Trimester Screening Results
    • Second Trimester Screening Results
    • Screening for Vanishing Twins Results
    • Non-invasive Prenatal Testing (NIPT) Results
    • 11-14 Week (Nuchal Translucency) Ultrasound Results
    • 18-22 Week Ultrasound Results
    • Diagnostic Testing
  • For Providers-How to Order
    • enhanced First Trimester Screening (eFTS) Guide
    • Second Trimester Screening (STS) Guide
    • Non-Invasive Prenatal Testing (NIPT) Guide
    • Screening for Vanishing Twins Guide
  • For Sonographers
    • Log in to the BIS
    • NT Registration
    • NT Quality Assurance
  • About Us
    • Careers
    • Events Calendar
    • Get Involved
    • Program Reports
    • PSO News
    • Subscribe to PSO updates
HomeFor Providers-How to Orderenhanced First Trimester Screening (eFTS) Guide
  • Open new window to share this page via Facebook Facebook
  • Open new window to share this page via LinkedIn LinkedIn
  • Open new window to share this page via Twitter Twitter
  • Email this page Email

black person looking at pregnancy test

enhanced First Trimester Screening (eFTS) Guide

Enhanced First Trimester Screening (eFTS) is a screening test for trisomy 21 and trisomy 18, consisting of a nuchal translucency ultrasound and bloodwork in the first trimester of pregnancy. This test is the preferred multiple marker screening modality.

Step-by-step instructions are outlined below, to provide guidance to health-care providers for how to order eFTS  in Ontario. 

Step 1 |


Complete the Multiple Marker Screening Requisition

Multiple Marker Screening (MMS) is done by 3 provincial laboratories: Trillium Health Partners - Credit Valley Hospital, Mount Sinai Hospital and North York General Hospital. Check out our interactive map to learn which of the three requisitions you should use. 

screenshot of MMS req NYGH
North York General Hospital Requisition
screenshot MMS req THP
Trillium Health Partners - Credit Valley Hospital Requisition
screenshot MSH
Mount Sinai Hospital Requisition

The Multiple Marker Screening Requisition must be completed in full prior to NT ultrasound. Please note that missing information decreases the quality of the screen and can potentially delay the results.

Demographics Section

The pregnant individual’s name, date of birth, health card number, address, and phone number should be completed.

"Test Requested" Section

Check off the enhanced First Trimester Screening (eFTS) option only for:

  • Singleton pregnancies. eFTS cannot be done for twin pregnancies. If you are aware of a twin pregnancy prior to filling out this requisition, offer OHIP-funded NIPT instead.
  • Pregnancies without a vanishing twin/co-twin demise. If you are aware of a vanishing twin scenario prior to filling out this requisition, order "NT + Second Trimester Screening”.
  • Pregnancies under 13 weeks 3 days gestation. eFTS is available when the crown-rump length measurement (the measurement of the length of embryo from top of the head to the bottom of the torso) at the time of NT ultrasound is between 45 and 84 mm. This corresponds to a gestation between 11 weeks 2 days to 13 weeks 3 days gestation1.

  • Pregnancies for which NIPT has not been ordered.

  • Pregnancies for which NIPT has been ordered, but has been uninformative.

1The Multiple Marker Screening labs determine the gestational age based on the published tables of Hadlock and Daya.

  1. Hadlock, F.P., Deter, R.L., Harrist. R.B., Park, S.K. (1982). Fetal biparietal diameter: a critical re-evaluation of the relation to menstrual age by means of real-time ultrasound. J Ultrasound Med 1(3):97–104. DOI: 10.7863/jum.1982.1.3.97
  2. Daya, S. (1993) Accuracy of gestational age estimations by means of fetal crown-rump length measurement. Am J Obstet Gynecol 168(3 Pt 1):903–8. DOI: https://doi.org/10.1016/S0002-9378(12)90842-X

 "Clinical Information" Section

Accurate and complete information in this section will increase the quality  of the screening results by reducing the chance of false positives and false negatives. 

Example of statement you can make when speaking with pregnant individuals:

I have some questions about you to ask to make sure your screening is as accurate as possible.

Racial Origin of Oocyte

Indicate the racial origin of the oocyte (egg) provider, which is usually the pregnant individual. In cases of egg donation, indicate the racial origin of the oocyte (egg) provider, not that of the pregnant individual.

Racial origin information is needed because the concentrations of screening markers have been shown to vary depending on the racial origin. Therefore, a pregnant individual’s screening markers are adjusted based on the racial origin information provided.

Only the broad racial origins listed are needed for screening marker adjustment. The categories on this requisition are not inclusive of all the race categories commonly used as social descriptors in Ontario. 

Description / examples for each of the racial origin categories on the requisition:

  • Asian: South Asian (E.g. East Indian, Pakistani, Bangladeshi, Sri Lankan, Indo-Caribbean etc.), East/Southeast Asian (e.g. Chinese, Korean, Japanese, Filipino, Indonesian, Thai) descent
  • Black: African, Afro-Caribbean descent
  • Indigenous: First Nations, Metis, Inuk/Inuit descent
  • White: European, Middle Eastern descent (e.g. Arab, Persian, Afhgan, Egyptian, Lebanese, Turkish, Kurdish)
  • Other: Another race category or mixed racial origin

Racial origin should be as accurate as possible and should reflect the individual’s ancestral background (which may or may not align with how the pregnant individual identifies), not simply their birth country. This information should be obtained directly from the pregnant individual whenever possible.

Example of question you can ask pregnant individuals:

In our society, people are often described by their race or racial background. For example, some people are considered “White”, “Black”, or “South Asian”. How would you identify or describe your racial background?

Weight

Indicate the pregnant individual’s weight, including units (pounds (lbs) versus kilograms (kg)), at the time when this requisition is completed. This information is used for screening marker adjustments. Ensure the weight that you document is accurate. A weight discrepancy of 5 or more pounds (2.3 kilograms) has a significant impact on the risk for trisomy 21 for pregnant individuals with a risk close to the screening cut-off. 

Example of questions you can ask if the weight is not obtained at the time of appointment:

  • What do you think is your current weight? 
  • Do you think the weight your provided is accurate within 5 pounds? 
Last Menstrual Period

The Last Menstrual Period (LMP) is not needed for eFTS. The crown-rump length measurement at the time of NT ultrasound is used instead of the LMP to establish the gestational age of the fetus.

Insulin-Dependent Diabetes Mellitus History

Indicate if insulin-dependent Diabetes Mellitus was diagnosed prior to the individual’s current pregnancy. Individuals with insulin-dependent Diabetes Mellitus have been shown to have different concentrations of screening markers compared to those who do not have this diagnosis. Screening marker adjustments must be made to account for these differences.

No screening marker adjustments are made for pregnant individuals with a history of gestational diabetes or preexisting diabetes that is not managed with insulin.

Example of questions you can ask pregnant individuals:

  • Do you have a diagnosis of diabetes? 
  • Was the diabetes diagnosed before the current pregnancy?
  • Do you use insulin to manage the diabetes? 
Cigarette Smoking History

Indicate if the pregnant individual has smoked any amount of tobacco at any point in the current pregnancy. Individuals with a history of smoking tobacco in their current pregnancy have been shown to have different concentrations of screening markers compared to those who do not have this history. Screening marker adjustments must be made to account for these differences. 

If the requisition does not include information about the smoking history, the pregnant individual is considered a non-smoker. Due to lack of published data, pregnant individuals exposed to second-hand smoke are considered non-smokers. 

Example of question you can ask pregnant individuals:

Have you smoked any cigarettes at any point in the current pregnancy? 

In Vitro Fertilization (IVF) History

If the pregnancy was conceived using in vitro fertilization (IVF), indicate the egg harvest date and date of birth of the egg donor (either self or non-self). If the egg donor's full date of birth is unknown, indicate the year of birth. If only the year of the donor date of birth is provided, July 1 of the provided year is used as the date.

This information is requested because the age of the egg at the date of delivery influences the enhanced First Trimester Screening risk. In addition, screening marker levels vary between IVF and natural conceptions, and screening marker adjustments must be made to account for these differences.

Examples of questions you can ask pregnant individuals:

  • Did the current pregnancy happen through in vitro fertilization (IVF)? 
  • What was the egg harvest date?
  • Were your own eggs used for this pregnancy, or was there an egg donor involved? 
  • Do you know the date of birth of the egg donor; at minimum, the year of birth?  

"Ultrasound Information" Section

Be aware that only the sonographer / physician performing the NT scan completes the "Ultrasound Information" section when ordering eFTS.

 If a suspected or confirmed vanishing twin/co-twin demise is identified on the NT ultrasound

If a suspected or confirmed vanishing twin/co-twin demise is identified on the NT ultrasound, the sonographer / physician performing the scan checks off “Confirmed or suspected vanishing twin/co-twin demise identified on this U/S” in this section. Checking this box signifies to the MMS lab that NT + STS needs to be performed. The pregnant individual is to proceed with the blood draw, and upon receipt of the blood sample, the MMS lab notifies you of the next steps, which would be to arrange an STS blood draw between 14 weeks 0 days to 20 weeks 6 days (and 8 weeks after the estimated date of demise).

 If a twin pregnancy is identified on the NT ultrasound

If a twin pregnancy is identified on the NT ultrasound, the sonographer / physician performing the scan checks off “Viable twin pregnancy identified on this U/S” in this section.  Checking off this box signifies to the MMS lab that this is a twin pregnancy, therefore eFTS cannot be performed. The pregnant individual is to proceed with the blood draw, and upon receipt of the blood sample, the MMS lab notifies you that First Trimester Screening for twin pregnancies has been discontinued in Ontario and that OHIP-funded NIPT should be ordered instead. 

Step 2 | 


Complete a Nuchal Translucency Ultrasound Requisition


Visit our interactive map to find facilities offering NT ultrasound in Ontario. You can contact the ultrasound facility of interest to obtain the centre-specific ultrasound requisition

image of ultrasound and tech

Step 3 |


Provide Requisitions to the Pregnant Individual

  • Give both the completed nuchal translucency ultrasound requisition and Multiple Marker Screening requisition to the pregnant individual.
  • If your office is booking the NT ultrasound, it is helpful to fax the MMS requisition with the ultrasound requisition to the ultrasound facility. It is important that the ultrasound facility has both of these requisitions at the time of the ultrasound appointment, either from your office or from the pregnant individual.
  • Check if additional requisitions are required by the ultrasound and blood work facilities, such as the Ministry of Health and Long Term Care Laboratory Requisition.

woman holding a form

Step 4 |


Provide Step-by-Step Instructions to the Pregnant Individual

  • Provide clear instructions to pregnant individual for how to navigate the different steps involved in obtaining enhanced First Trimester Screening, as outlined in the leaflet. Please note that Prenatal Screening Ontario does not organize prenatal genetic screening tests, such as the NT ultrasound. 
  • If the pregnant individual goes for the NT ultrasound but the bloodwork is not done prior to 13 weeks 3 days gestation, eFTS may not be possible for the pregnant individual in your care.  Contact Prenatal Screening Ontario or the Multiple Marker Screening Laboratory to learn about which screening options are possible.
screenshot of how to get eFTS leaflet
Share with Pregnant Individuals: How to Get eFTS Leaflet

Step 5 |


Obtain Report and Check for Accuracy

  • Results are reported to you by the MMS lab generally within 5 business days. It is important to take into account the time lag that can occur between the time when the report is ready and when it is received by your office.
  • If you do not receive the prenatal screening report, we encourage you to follow up with the MMS lab directly. Prenatal Screening Ontario does not have access to screening results of individuals. 
  • Review the screening report for accuracy. If any errors or omissions are noted, contact the MMS Laboratory to determine if an amendment to the report is needed.

When is a Report Amended?

A report is considered “amended” if changes are made after the report has been issued to the health-care provider. Amending reports is necessary to correct errors that include data being inaccurately provided on the requisition. Some examples are inaccurate racial origin identification, inaccurate diabetes status, and correction of weight, due to either wrong units (i.e. pounds or kilograms) or difference in weight of more than 5 - 10 pounds (2.3 - 4.6 kilograms)1 from that given on the requisition.

1North York General Hospital and Mount Sinai Hospital labs will amend a report if there is a difference in weight of more than 10 pounds. The Trillium Health Partners lab will amend a report if there is a difference in weight of more than 5 pounds. 

How is a Report Amended?

Health-care providers can write the amendment(s) directly on the screening report and fax it back to the Multiple Marker Screening Laboratory, indicating that an amendment is required as per the enclosed report. Alternatively, the health-care provider can fax a note with the pregnant individual's name, date of birth, health card number, and details related to the amendment request, including relevant clinical information. 

Step 6 |


Communicate Results and Next Steps

  • Once the report is received, results should be communicated in both “screen positive” and “screen negative” scenarios, including the specific risk estimate provided on the report.
  • Ensure continuity of care: forward the report to any other providers involved in the care of the pregnant individual.

The results of the nuchal translucency ultrasound will be sent separately by the ultrasound facility. If the nuchal translucency measurement is increased (3.5 mm or above), inform the pregnant individual of this result as soon as possible and offer a referral for genetic counselling irrespective of the eFTS results

screenshot of how to discuss results leaflet
Point-of-Care Tool: How to Discuss Multiple Marker Screening Results
  • For Providers-How to Order
    • enhanced First Trimester Screening (eFTS) Guide
    • Second Trimester Screening (STS) Guide
    • Non-Invasive Prenatal Testing (NIPT) Guide
    • Screening for Vanishing Twins Guide

Contact Us

Subscribe to this page

Prenatal Screening Ontario logo

BORN Ontario logo

Our Website

  • What We Screen For In Ontario
  • Prenatal Screening Options
  • Results and Next Steps
  • For Providers-How to Order
  • For Sonographers

Helpful Links

  • Contact Us
  • Sitemap
  • Website Feedback
  • View our Facebook Page
  • View our Twitter Page

Contact us

Prenatal Screening Ontario 
CHEO Research Institute 
Centre for Practice-Changing Research Building 
401 Smyth Road 
Ottawa, ON K1H 8L1

Phone: 613-737-2281

Toll-Free: 1-833-351-6490

Monday to Friday, 9:00 AM to 3:00 PM EST

Copyright © 2022 BORN Ontario | Funded by the Government of Ontario

Designed by eSolutionsGroup

Close Old Browser Notification
Browser Compatibility Notification
It appears you are trying to access this site using an outdated browser. As a result, parts of the site may not function properly for you. We recommend updating your browser to its most recent version at your earliest convenience.